|
Market Closed -
Nasdaq
21:00:00 23/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 2.130 USD | -1.84% |
|
-13.41% | -37.54% |
| 08-06 | B. Riley Adjusts Price Target on LifeMD to $8 From $10, Maintains Buy Rating | MT |
| 08-05 | LifeMD, Inc., Q2 2026 Earnings Call, Aug 05, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Medical Software & Technology Services
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 103M | - | - | - | ||
| 250B | |||||
| 162B | |||||
| 154B | |||||
| 66.68B | |||||
| 52.08B |
- Stock Market
- Stocks
- LFMD Stock
- Charts LifeMD, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
